Explore our work below:
Fighting Superbugs: Ensuring Australia is ready to combat the rise of drug resistant infections
Evohealth is proud to partner with the Australian Antimicrobial Resistance Network and MTPConnect to publish the second in the Fighting superbugs series of reports. Fighting Superbugs: Ensuring Australia is ready to combat the rise of drug resistant infections.
Cell and gene therapies: Rising to the challenge Scorecard 2023
Cell and Gene Therapies, or CGTs, are at the forefront of medical innovation. Unlike conventional medicines, these powerful new therapies target…
Time to Act: protecting our children from RSV
Respiratory syncytial virus (RSV) is the leading cause of hospitalisation for Australian infants and children under 5 years, yet it does not receive…
Connecting Nurses to Nurses
With our proximity to the equator, high proportion of fair skinned people and enjoyment of the great outdoors, exposure to harmful UV rays is a daily risk for many Australians…
CAR T-cell therapy: Is Australia ready, willing and able?
Multiple myeloma is a devastating and incurable disease affecting thousands of Australians and their families. Patients endure…
Shining a light: Radiotherapy cancer treatment in Australia
In Australia, there is one new cancer diagnosis every four minutes. Australia spends over $10 billion per year diagnosing and treating cancer. For patients, navigating the cancer clinical pathway can be confusing, complex, and stressful.
ASCVD in Taiwan: A public health priority
Cardiovascular disease (CVD) is a leading cause of morbidity and mortality globally – and yet, if identified early, 90…
Cell and gene therapies: Rising to the challenge
Our White Paper examines how prepared Australia’s health system is for the many CGTs anticipated in the coming years….